An Introduction to the Ethical Design, Conduct, and Analysis of Pediatric Clinical Trials

Myron Yaster, Jeffrey Galinkin, Mark S. Schreiner

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Few drugs administered to infants and children have been studied for efficacy and safety in these patients. The randomized, blinded, placebo-controlled clinical trial is the indispensable "gold standard" for determining the efficacy of therapeutics. Trials are time consuming, maddeningly difficult and often very expensive to perform, and frustrating from inception to execution to completion. However, the failure to properly perform a trial results in perpetual uncertainty and possibly patient harm. Performing a proper trial takes time to develop a protocol, create and test the data collection forms, obtain support and funding, and establish the structure for data intake and analysis. Once completed, the results of the trial must be published and made available to the public and regulatory agencies. Finally, above all else, all aspects of trial conduct must adhere to accepted ethical standards.

Original languageEnglish (US)
Title of host publicationGregory's Pediatric Anesthesia: Fifth Edition
PublisherWiley-Blackwell
Pages40-59
Number of pages20
ISBN (Print)1444333461, 9781444333466
DOIs
StatePublished - Dec 9 2011

Fingerprint

Clinical Trials
Pediatrics
Patient Harm
Controlled Clinical Trials
Patient Safety
Uncertainty
Placebos
Pharmaceutical Preparations
Therapeutics

Keywords

  • Acceptable risk
  • Children
  • Clinical trials
  • Committee on human research
  • Controlled trials
  • Ethics
  • Masking
  • Outcome measures
  • Randomization
  • Randomized
  • Recruitment
  • Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Yaster, M., Galinkin, J., & Schreiner, M. S. (2011). An Introduction to the Ethical Design, Conduct, and Analysis of Pediatric Clinical Trials. In Gregory's Pediatric Anesthesia: Fifth Edition (pp. 40-59). Wiley-Blackwell. https://doi.org/10.1002/9781444345186.ch4

An Introduction to the Ethical Design, Conduct, and Analysis of Pediatric Clinical Trials. / Yaster, Myron; Galinkin, Jeffrey; Schreiner, Mark S.

Gregory's Pediatric Anesthesia: Fifth Edition. Wiley-Blackwell, 2011. p. 40-59.

Research output: Chapter in Book/Report/Conference proceedingChapter

Yaster, M, Galinkin, J & Schreiner, MS 2011, An Introduction to the Ethical Design, Conduct, and Analysis of Pediatric Clinical Trials. in Gregory's Pediatric Anesthesia: Fifth Edition. Wiley-Blackwell, pp. 40-59. https://doi.org/10.1002/9781444345186.ch4
Yaster M, Galinkin J, Schreiner MS. An Introduction to the Ethical Design, Conduct, and Analysis of Pediatric Clinical Trials. In Gregory's Pediatric Anesthesia: Fifth Edition. Wiley-Blackwell. 2011. p. 40-59 https://doi.org/10.1002/9781444345186.ch4
Yaster, Myron ; Galinkin, Jeffrey ; Schreiner, Mark S. / An Introduction to the Ethical Design, Conduct, and Analysis of Pediatric Clinical Trials. Gregory's Pediatric Anesthesia: Fifth Edition. Wiley-Blackwell, 2011. pp. 40-59
@inbook{20e0cf325b6349bbbbbc93c44229274f,
title = "An Introduction to the Ethical Design, Conduct, and Analysis of Pediatric Clinical Trials",
abstract = "Few drugs administered to infants and children have been studied for efficacy and safety in these patients. The randomized, blinded, placebo-controlled clinical trial is the indispensable {"}gold standard{"} for determining the efficacy of therapeutics. Trials are time consuming, maddeningly difficult and often very expensive to perform, and frustrating from inception to execution to completion. However, the failure to properly perform a trial results in perpetual uncertainty and possibly patient harm. Performing a proper trial takes time to develop a protocol, create and test the data collection forms, obtain support and funding, and establish the structure for data intake and analysis. Once completed, the results of the trial must be published and made available to the public and regulatory agencies. Finally, above all else, all aspects of trial conduct must adhere to accepted ethical standards.",
keywords = "Acceptable risk, Children, Clinical trials, Committee on human research, Controlled trials, Ethics, Masking, Outcome measures, Randomization, Randomized, Recruitment, Research",
author = "Myron Yaster and Jeffrey Galinkin and Schreiner, {Mark S.}",
year = "2011",
month = "12",
day = "9",
doi = "10.1002/9781444345186.ch4",
language = "English (US)",
isbn = "1444333461",
pages = "40--59",
booktitle = "Gregory's Pediatric Anesthesia: Fifth Edition",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - An Introduction to the Ethical Design, Conduct, and Analysis of Pediatric Clinical Trials

AU - Yaster, Myron

AU - Galinkin, Jeffrey

AU - Schreiner, Mark S.

PY - 2011/12/9

Y1 - 2011/12/9

N2 - Few drugs administered to infants and children have been studied for efficacy and safety in these patients. The randomized, blinded, placebo-controlled clinical trial is the indispensable "gold standard" for determining the efficacy of therapeutics. Trials are time consuming, maddeningly difficult and often very expensive to perform, and frustrating from inception to execution to completion. However, the failure to properly perform a trial results in perpetual uncertainty and possibly patient harm. Performing a proper trial takes time to develop a protocol, create and test the data collection forms, obtain support and funding, and establish the structure for data intake and analysis. Once completed, the results of the trial must be published and made available to the public and regulatory agencies. Finally, above all else, all aspects of trial conduct must adhere to accepted ethical standards.

AB - Few drugs administered to infants and children have been studied for efficacy and safety in these patients. The randomized, blinded, placebo-controlled clinical trial is the indispensable "gold standard" for determining the efficacy of therapeutics. Trials are time consuming, maddeningly difficult and often very expensive to perform, and frustrating from inception to execution to completion. However, the failure to properly perform a trial results in perpetual uncertainty and possibly patient harm. Performing a proper trial takes time to develop a protocol, create and test the data collection forms, obtain support and funding, and establish the structure for data intake and analysis. Once completed, the results of the trial must be published and made available to the public and regulatory agencies. Finally, above all else, all aspects of trial conduct must adhere to accepted ethical standards.

KW - Acceptable risk

KW - Children

KW - Clinical trials

KW - Committee on human research

KW - Controlled trials

KW - Ethics

KW - Masking

KW - Outcome measures

KW - Randomization

KW - Randomized

KW - Recruitment

KW - Research

UR - http://www.scopus.com/inward/record.url?scp=84885536249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885536249&partnerID=8YFLogxK

U2 - 10.1002/9781444345186.ch4

DO - 10.1002/9781444345186.ch4

M3 - Chapter

AN - SCOPUS:84885536249

SN - 1444333461

SN - 9781444333466

SP - 40

EP - 59

BT - Gregory's Pediatric Anesthesia: Fifth Edition

PB - Wiley-Blackwell

ER -